Literature DB >> 24513118

Peroxisome proliferator-activated receptor β/δ (PPARβ/δ) protects against ceramide-induced cellular toxicity in rat brain astrocytes and neurons by activation of ceramide kinase.

Stepan Aleshin1, Georg Reiser2.   

Abstract

Peroxisome proliferator-activated receptors (PPARs) are important members of the nuclear receptor superfamily. Ligands of these nuclear receptors (PPARα, β/δ and γ) belong to a wide range of lipophilic substances. In spite of the proven neuroprotective efficacy of PPARβ/δ in models of neurological diseases, the biology of PPARβ/δ in the brain has been much less investigated than that of PPARα and PPARγ. In the present study, we test the hypothesis that neuroprotection induced by PPARβ/δ could rely on the regulation of ceramide metabolism. We found that preincubation of neural cells with the PPARβ/δ agonist L-165041 exerts significant protection against ceramide-induced cell death. Most importantly, L-165041 protects against ceramide-induced cell death not only before the insult, but also after the onset of the insult. To identify the mechanism of protection, we show that L-165041 upregulates ceramide kinase (CerK) expression levels in neural cells. Consistent with that, we detected that pharmacological inhibition of CerK reduces the protective effects of L-165041. To further decipher the mechanism of protection, gene knockdown in astrocytes was studied. Knockdown of PPARβ/δ and CerK in astrocytes was used to verify that the protective effects of L-165041 are CerK- and PPARβ/δ-dependent. We demonstrate that in CerK- or PPARβ/δ-knockdown astrocytes, addition of L-165041 has no protective effect. Thus, we conclude that PPARβ/δ protects neural cells against ceramide-induced cell death via induction and activation of CerK.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Neurodegeneration; Neuroprotection; Peroxisome proliferator-activated receptors; Transcription factor

Mesh:

Substances:

Year:  2014        PMID: 24513118     DOI: 10.1016/j.mcn.2014.01.008

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  5 in total

Review 1.  Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer's Disease.

Authors:  Suzanne M de la Monte
Journal:  Drugs       Date:  2017-01       Impact factor: 9.546

Review 2.  Metabolic and Inflammatory Adaptation of Reactive Astrocytes: Role of PPARs.

Authors:  José Iglesias; Ludis Morales; George E Barreto
Journal:  Mol Neurobiol       Date:  2016-03-17       Impact factor: 5.590

3.  Supplementation of Enriched Polyunsaturated Fatty Acids and CLA Cheese on High Fat Diet: Effects on Lipid Metabolism and Fat Profile.

Authors:  Monica Tognocchi; Maria Conte; Lara Testai; Morena Martucci; Andrea Serra; Stefano Salvioli; Vincenzo Calderone; Marcello Mele; Giuseppe Conte
Journal:  Foods       Date:  2022-01-29

4.  PPARβ/δ-agonist GW0742 ameliorates dysfunction in fatty acid oxidation in PSEN1ΔE9 astrocytes.

Authors:  Henna Konttinen; Irina Gureviciene; Minna Oksanen; Alexandra Grubman; Sanna Loppi; Mikko T Huuskonen; Paula Korhonen; Riikka Lampinen; Meike Keuters; Irina Belaya; Heikki Tanila; Katja M Kanninen; Gundars Goldsteins; Gary Landreth; Jari Koistinaho; Tarja Malm
Journal:  Glia       Date:  2018-11-19       Impact factor: 8.073

Review 5.  The Role of Sphingosine-1-Phosphate and Ceramide-1-Phosphate in Inflammation and Cancer.

Authors:  Nitai C Hait; Aparna Maiti
Journal:  Mediators Inflamm       Date:  2017-11-15       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.